Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Golob-Schwarzl Nicole |

** = Publications listed in SCI/SSCI/Pubmed

2025

Full paper/article (Journal)

** Patra, V; Trajanoski, S; Joshi, A; Lenief, V; Goyet, C; Cornu, A; Golob-Schwarzl, N; Somlapura, M; Mosnier, A; Zarfl, M; Eichmann, T; Köefeler, H; Norval, M; Nicolas, JF; Wolf, P; Vocanson, M Urocanase-positive skin resident bacteria metabolize cis-urocanic acid and in turn reduce the immunosuppressive properties of UV radiation.
J Invest Dermatol. 2025; Doi: 10.1016/j.jid.2025.03.035
PubMed FullText FullText_MUG

 

2024

Full paper/article (Journal)

** Golob-Schwarzl, N; Pilic, J; Benezeder, T; Bordag, N; Painsi, C; Wolf, P Eukaryotic Initiation Factor 4E (eIF4E) as a Target of Anti-Psoriatic Treatment.
J Invest Dermatol. 2024; 144(3):500-508.e3 Doi: 10.1016/j.jid.2022.12.028
Web of Science PubMed FullText FullText_MUG

 

** Zarfl, M; Patra, V; Bordag, N; Quehenberger, F; Golob-Schwarzl, N; Gruber-Wackernagel, A; Wolf, P Eradication of skin microbiota restores cytokine production and release in polymorphic light eruption.
Exp Dermatol. 2024; 33(3):e15034 Doi: 10.1111/exd.15034
Web of Science PubMed FullText FullText_MUG

 

2023

Full paper/article (Journal)

** Kendzia, S; Franke, S; Kröhler, T; Golob-Schwarzl, N; Schweiger, C; Toeglhofer, AM; Skofler, C; Uranitsch, S; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Yaspo, ML; Reinhard, C; Schäfer, R; Keilholz, U; Regenbrecht, C; Schicho, R; Fickert, P; Lax, SF; Erdmann, F; Schulz, MH; Kiemer, AK; Haybaeck, J; Kessler, SM A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer.
Mol Cancer. 2023; 22(1):89 Doi: 10.1186/s12943-023-01787-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Krassnig, S; Leber, SL; Orthmann, A; Golob-Schwarzl, N; Huber, HJ; Wohlrab, C; Skofler, C; Pennauer, M; Raicht, A; Birkl-Toeglhofer, AM; Naumann, M; Mahdy-Ali, K; von, Campe, G; Leoni, M; Alcaniz, J; Hoffmann, J; Wälchli, T; Weis, S; Benesch, M; Haybaeck, J Decreased eukaryotic initiation factors expression upon temozolomide treatment-potential novel implications for eIFs in glioma therapy.
J Neurooncol. 2023; 165(1):91-100 Doi: 10.1007/s11060-023-04451-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Golob-Schwarzl, N; Pilic, J; Vrebo, A; Reinprecht, C; Benezeder, T; Bordag, N; Painsi, C; Wolf, P Bricilib - a new strategy for the treatment of psoriasis targeting eukaryotic translation initiation factor 4E
J INVEST DERMATOL. 2023; 143(11):S341-S341.-5th Inflammatory Skin Disease Summit (ISDS); NOV 15-18, 2023; Vienna, AUSTRIA. [Poster]
Web of Science

 

2022

Full paper/article (Journal)

** Regan, JL; Schumacher, D; Staudte, S; Steffen, A; Lesche, R; Toedling, J; Jourdan, T; Haybaeck, J; Golob-Schwarzl, N; Mumberg, D; Henderson, D; Győrffy, B; Regenbrecht, CRA; Keilholz, U; Schäfer, R; Lange, M Identification of a neural development gene expression signature in colon cancer stem cells reveals a role for EGR2 in tumorigenesis.
iScience. 2022; 25(7): 104498 Doi: 10.1016/j.isci.2022.104498 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Short report/Letter

** Golob-Schwarzl, N; Woltsche, N; Armento, A; Wolf, P; Horwath-Winter, J; Wedrich, A; Patra, V; Merle, DA SARS-CoV-2 spike protein functionally interacts with primary human conjunctival epithelial cells to induce a pro-inflammatory response.
Eye (Lond). 2022; 36(12):2353-2355 Doi: 10.1038/s41433-022-02066-7 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Golob-Schwarzl, N; Pilic, J; Benezeder, T; Bordag, N; Painsi, C; Wolf, P Eukaryotic translation initiation factor 4E (eIF4E) as a target of anti-psoriatic treatment
J INVEST DERMATOL. 2022; 142(12): S244-S244. [Poster]
Web of Science

 

2021

Full paper/article (Journal)

** Graier, T; Golob-Schwarzl, N; Weger, W; Benezeder, T; Painsi, C; Salmhofer, W; Wolf, P Furin Expression in Patients With Psoriasis-A Patient Cohort Endangered to SARS-COV2?
Front Med (Lausanne). 2021; 8: 624462-624462. Doi: 10.3389/fmed.2021.624462 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Krassnig, S; Wohlrab, C; Golob-Schwarzl, N; Raicht, A; Schatz, C; Birkl-Toeglhofer, AM; Skofler, C; Gantenbein, N; Leoni, M; Asslaber, M; Leber, SL; Mahdy-Ali, K; von Campe, G; Mayer, M; Borenich, A; Weis, S; Benesch, M; Haybaeck, J A Profound Basic Characterization of eIFs in Gliomas: Identifying eIF3I and 4H as Potential Novel Target Candidates in Glioma Therapy.
Cancers (Basel). 2021; 13(6): Doi: 10.3390/cancers13061482 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kuscuoglu, D; Bewersdorf, L; Wenzel, K; Gross, A; Kobazi Ensari, G; Luo, Y; Kilic, K; Hittatiya, K; Golob-Schwarzl, N; Leube, RE; Preisinger, C; George, J; Metwally, M; Eslam, M; Lampertico, P; Petta, S; Mangia, A; Berg, T; Boonstra, A; Brouwer, WP; Abate, ML; Loglio, A; Sutton, A; Nahon, P; Schaefer, B; Zoller, H; Aigner, E; Trautwein, C; Haybaeck, J; Strnad, P Dual proteotoxic stress accelerates liver injury via activation of p62-Nrf2.
J Pathol. 2021; 254(1):80-91 Doi: 10.1002/path.5643
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf, P Eukaryotic Translation Initiation Factors (eIFs): Potential Therapeutic Targets in Psoriasis
J INVEST DERMATOL. 2021; 141(10): S177-S177. [Poster]
Web of Science

 

** Golob-Schwarzl, N; Pilic, J; Benezeder, T; Painsi, C; Wolf, P Eukaryotic Translation Initiation Factors (eIFs): Potential therapeutic targets in psoriasis
EXP DERMATOL. 2021; 30: 5-6. [Oral Communication]
Web of Science

 

2020

Full paper/article (Journal)

** Golob-Schwarzl, N; Puchas, P; Gogg-Kamerer, M; Weichert, W; Göppert, B; Haybaeck, J New Pancreatic Cancer Biomarkers eIF1, eIF2D, eIF3C and eIF6 Play a Major Role in Translational Control in Ductal Adenocarcinoma.
Anticancer Res. 2020; 40(6):3109-3118 Doi: 10.21873/anticanres.14292 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Xu, J; Guo, J; Golob-Schwarzl, N; Haybaeck, J; Qiu, X; Hildebrandt, N Single-Measurement Multiplexed Quantification of MicroRNAs from Human Tissue Using Catalytic Hairpin Assembly and Förster Resonance Energy Transfer.
ACS Sens. 2020; 5(6):1768-1776 Doi: 10.1021/acssensors.0c00432
Web of Science PubMed FullText FullText_MUG

 

Correction

** Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Müller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rülicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J Corrigendum to High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype12 [Translational Oncology Volume 12, Issue 2, February 2019, Pages 256-268].
Transl Oncol. 2020; 13(2):490-492 Doi: 10.1016/j.tranon.2019.08.001 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2019

Full paper/article (Journal)

** Golob-Schwarzl, N; Bettermann, K; Mehta, AK; Kessler, SM; Unterluggauer, J; Krassnig, S; Kojima, K; Chen, X; Hoshida, Y; Bardeesy, NM; Müller, H; Svendova, V; Schimek, MG; Diwoky, C; Lipfert, A; Mahajan, V; Stumptner, C; Thüringer, A; Fröhlich, LF; Stojakovic, T; Nilsson, KPR; Kolbe, T; Rülicke, T; Magin, TM; Strnad, P; Kiemer, AK; Moriggl, R; Haybaeck, J High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype.
Transl Oncol. 2019; 12(2):256-268 Doi: 10.1016/j.tranon.2018.10.010 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Golob-Schwarzl, N; Wodlej, C; Kleinegger, F; Gogg-Kamerer, M; Birkl-Toeglhofer, AM; Petzold, J; Aigelsreiter, A; Thalhammer, M; Park, YN; Haybaeck, J Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer.
J Cancer Res Clin Oncol. 2019; 145(11): 2699-2711. Doi: 10.1007/s00432-019-03030-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Grill, M; Högenauer, C; Blesl, A; Haybaeck, J; Golob-Schwarzl, N; Ferreirós, N; Thomas, D; Gurke, R; Trötzmüller, M; Köfeler, HC; Gallé, B; Schicho, R Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer.
Sci Rep. 2019; 9(1): 2358-2358. Doi: 10.1038/s41598-019-38865-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kaltenecker, D; Themanns, M; Mueller, KM; Spirk, K; Golob-Schwarzl, N; Friedbichler, K; Kenner, L; Haybaeck, J; Moriggl, R STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice.
Cytokine. 2018; 154573-154573 Doi: 10.1016/j.cyto.2018.10.014 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kessler, SM; Leber, B; Hoppstädter, J; Golob-Schwarzl, N; Hofer, EM; Schultheiss, CS; Mischinger, HJ; Liegl-Atzwanger, B; Lackner, C; Stiegler, P; Haybaeck, J Diethylnitrosamine (DENA) recapitulates formation of hepatic angiosarcoma in pigs.
PLoS One. 2019; 14(5):e0214756-e0214756 Doi: 10.1371/journal.pone.0214756 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kleinegger, F; Hofer, E; Wodlej, C; Golob-Schwarzl, N; Birkl-Toeglhofer, AM; Stallinger, A; Petzold, J; Orlova, A; Krassnig, S; Reihs, R; Niedrist, T; Mangge, H; Park, YN; Thalhammer, M; Aigelsreiter, A; Lax, S; Garbers, C; Fickert, P; Rose-John, S; Moriggl, R; Rinner, B; Haybaeck, J Pharmacologic IL-6Rα inhibition in cholangiocarcinoma promotes cancer cell growth and survival.
Biochim Biophys Acta Mol Basis Dis. 2019; 1865(2):308-321 Doi: 10.1016/j.bbadis.2018.11.006 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Czapiewski, P; Lapińska-Szumczyk, S; Majewska, H; Supernat, A; Zaczek, A; Biernat, W; Golob-Schwarzl, N; Haybaeck, J The Prognostic Significance of Eukaryotic Translation Initiation Factors (eIFs) in Endometrial Cancer.
Int J Mol Sci. 2019; 20(24): Doi: 10.3390/ijms20246169 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2018

Full paper/article (Journal)

** Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Krassnig, S; Wodlej, C; Brcic, L; Lindenmann, J; Fink-Neuboeck, N; Gollowitsch, F; Stacher-Priehse, E; Asslaber, M; Gogg-Kamerer, M; Rolff, J; Hoffmann, J; Silvestri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Sokolova, O; Naumann, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J Influence of eukaryotic translation initiation factor 6 on non-small cell lung cancer development and progression.
Eur J Cancer. 2018; 101(4):165-180 Doi: 10.1016/j.ejca.2018.07.001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Qiu, X; Xu, JY; Guo, JJ; Yahia-Ammar, A; Kapetanakis, NI; Duroux-Richard, I; Unterluggauer, JJ; Golob-Schwarzl, N; Regeard, C; Uzan, C; Gouy, S; Dubow, M; Haybaeck, J; Apparailly, F; Busson, P; Hildebrandt, N Advanced microRNA-based cancer diagnostics using amplified time-gated FRET
CHEM SCI. 2018; 9(42): 8046-8055. Doi: 10.1039/c8sc03121e [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Golob-Schwarzl, N; Wodlej, C; Kleinegger, F; Toeglhofer, AM; Krassnig, S; Thalhammer, M; Aigelsreiter, A; Hayback, J Eukaryotic Translation Initiation Factors Might Represent a Potential Therapeutic Target for Gallbladder Cancer
ONCOL RES TREAT. 2018; 41: 68-68.-33. Deutscher Krebs Kongress; FEB 21-24, 2018; Berlin, GERMANY. [Poster]
Web of Science

 

** Wodlej, C; Krassnig, S; Golob-Schwarzl, N; Kleinegger, F; Toeglhofer, AM; Sygulla, S; Singer, G; Till, H; Izycka-Swieszewska, E; Czapiewski, P; Hayback, J The Role of Eukaryotic Translation Initiation Factors as Potential Targets in Neuroblastoma
ONCOL RES TREAT. 2018; 41: 131-131.-33. Deutscher Krebs Kongress; FEB, 21-24, 2018; Berlin, GERMANY. [Poster]
Web of Science

 

2017

Full paper/article (Journal)

** Golob-Schwarzl, N; Krassnig, S; Toeglhofer, AM; Park, YN; Gogg-Kamerer, M; Vierlinger, K; Schröder, F; Rhee, H; Schicho, R; Fickert, P; Haybaeck, J New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factors.
Eur J Cancer. 2017; 83(60):56-70 Doi: 10.1016/j.ejca.2017.06.003
Web of Science PubMed FullText FullText_MUG

 

** Golob-Schwarzl, N; Schweiger, C; Koller, C; Krassnig, S; Gogg-Kamerer, M; Gantenbein, N; Toeglhofer, AM; Wodlej, C; Bergler, H; Pertschy, B; Uranitsch, S; Holter, M; El-Heliebi, A; Fuchs, J; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Reinhard, C; Regenbrecht, C; Schicho, R; Fickert, P; Lax, S; Haybaeck, J Separation of low and high grade colon and rectum carcinoma by eukaryotic translation initiation factors 1, 5 and 6.
Oncotarget. 2017; 8(60):101224-101243 Doi: 10.18632/oncotarget.20642 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kessler, SM; Lederer, E; Laggai, S; Golob-Schwarzl, N; Hosseini, K; Petzold, J; Schweiger, C; Reihs, R; Keil, M; Hoffmann, J; Mayr, C; Kiesslich, T; Pichler, M; Kim, KS; Rhee, H; Park, YN; Lax, S; Obrist, P; Kiemer, AK; Haybaeck, J IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.
Oncotarget. 2017; 8(52):89736-89745 Doi: 10.18632/oncotarget.21116 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Regan, JL; Schumacher, D; Staudte, S; Steffen, A; Haybaeck, J; Keilholz, U; Schweiger, C; Golob-Schwarzl, N; Mumberg, D; Henderson, D; Lehrach, H; Regenbrecht, CRA; Schäfer, R; Lange, M Non-Canonical Hedgehog Signaling Is a Positive Regulator of the WNT Pathway and Is Required for the Survival of Colon Cancer Stem Cells.
Cell Rep. 2017; 21(10):2813-2828 Doi: 10.1016/j.celrep.2017.11.025 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schütte, M; Risch, T; Abdavi-Azar, N; Boehnke, K; Schumacher, D; Keil, M; Yildiriman, R; Jandrasits, C; Borodina, T; Amstislavskiy, V; Worth, CL; Schweiger, C; Liebs, S; Lange, M; Warnatz, HJ; Butcher, LM; Barrett, JE; Sultan, M; Wierling, C; Golob-Schwarzl, N; Lax, S; Uranitsch, S; Becker, M; Welte, Y; Regan, JL; Silvestrov, M; Kehler, I; Fusi, A; Kessler, T; Herwig, R; Landegren, U; Wienke, D; Nilsson, M; Velasco, JA; Garin-Chesa, P; Reinhard, C; Beck, S; Schäfer, R; Regenbrecht, CR; Henderson, D; Lange, B; Haybaeck, J; Keilholz, U; Hoffmann, J; Lehrach, H; Yaspo, ML Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.
Nat Commun. 2017; 8(2):14262-14262 Doi: 10.1038/ncomms14262 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Taniguchi, K; Moroishi, T; de Jong, PR; Krawczyk, M; Grebbin, BM; Luo, H; Xu, RH; Golob-Schwarzl, N; Schweiger, C; Wang, K; Di Caro, G; Feng, Y; Fearon, ER; Raz, E; Kenner, L; Farin, HF; Guan, KL; Haybaeck, J; Datz, C; Zhang, K; Karin, M YAP-IL-6ST autoregulatory loop activated on APC loss controls colonic tumorigenesis.
Proc Natl Acad Sci U S A. 2017; 114(7):1643-1648 Doi: 10.1073/pnas.1620290114 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Gantenbein, N; Bernhart, E; Anders, I; Golob-Schwarzl, N; Gogg-Kammerer, M; Lindenmann, J; Fink-Neuboeck, N; Brcic, L; Gollowitsch, F; Stacher-Priehse, E; Rolff, J; Hoffmann, J; Silvestri, A; Regenbrecht, C; Reinhard, C; Pehserl, AM; Pichler, M; Mitterer, V; Pertschy, B; Bergler, H; Popper, H; Sattler, W; Haybaeck, J Eukaryotic translation initiation factors impact non small cell lung cancer
VIRCHOWS ARCH. 2017; 471: S104-S104. [Poster]
Web of Science

 

** Kleinegger, F; Golob-Schwarzl, N; Toeglhofer, AM; Baran, P; Krassnig, S; Niedrist, T; Speicher, I; Rinner, B; Thalhammer, M; Aigelsreiter, A; Lackner, C; Scheller, J; Rose-John, S; Fickert, P; Haybaeck, J Interleukin-6 Receptor influences cholangiocarcinoma progression
VIRCHOWS ARCH. 2017; 471: S325-S326.-29th European Congress of Pathology; SEP 2-6, 2017; Amsterdam, The Netherlands. [Poster]
Web of Science

 

** Krassnig, S; Orthmann, A; Toeglhofer, AM; Wohlrab, C; Golob-Schwarzl, N; Wodlej, C; Pennauer, M; Raicht, A; Ali, KM; von Campe, G; Gogg-Kamerer, M; Logi, M; Sygulla, S; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J Eukaryotic initiation factors might not only represent novel targets for glioma therapies but might also monitor drug effectiveness
VIRCHOWS ARCH. 2017; 471: S46-S46. [Oral Communication]
Web of Science

 

** Toeglhofer, AM; Krassnig, S; Golob-Schwarzl, N; Wodlej, C; Birkl, C; Kalev, O; Leoni, M; Flunkert, S; Hutter-Paier, B; Weis, S; Haybaeck, J Eukaryotic initiation factors are altered in Alzheimer's disease
VIRCHOWS ARCH. 2017; 471: S218-S219. [Poster]
Web of Science

 

2016

Full paper/article (Journal)

** Barghash, A; Golob-Schwarzl, N; Helms, V; Haybaeck, J; Kessler, SM Elevated expression of the IGF2 mRNA binding protein 2 (IGF2BP2/IMP2) is linked to short survival and metastasis in esophageal adenocarcinoma.
Oncotarget. 2016; 7(31):49743-49750 Doi: 10.18632/oncotarget.10439 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Bettermann, K; Mehta, AK; Hofer, EM; Wohlrab, C; Golob-Schwarzl, N; Svendova, V; Schimek, MG; Stumptner, C; Thüringer, A; Speicher, MR; Lackner, C; Zatloukal, K; Denk, H; Haybaeck, J Keratin 18-deficiency results in steatohepatitis and liver tumors in old mice: A model of steatohepatitis-associated liver carcinogenesis.
Oncotarget. 2016; 7(45):73309-73322 Doi: 10.18632/oncotarget.12325 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Birkl, C; Langkammer, C; Golob-Schwarzl, N; Leoni, M; Haybaeck, J; Goessler, W; Fazekas, F; Ropele, S Effects of formalin fixation and temperature on MR relaxation times in the human brain.
NMR Biomed. 2016; 29(4):458-465 Doi: 10.1002/nbm.3477
Web of Science PubMed FullText FullText_MUG

 

** Themanns, M; Mueller, KM; Kessler, SM; Golob-Schwarzl, N; Mohr, T; Kaltenecker, D; Bourgeais, J; Paier-Pourani, J; Friedbichler, K; Schneller, D; Schlederer, M; Zebedin-Brandl, E; Terracciano, LM; Han, X; Kenner, L; Wagner, KU; Mikulits, W; Kozlov, AV; Heim, MH; Gouilleux, F; Haybaeck, J; Moriggl, R Hepatic Deletion of Janus Kinase 2 Counteracts Oxidative Stress in Mice.
Sci Rep. 2016; 6(4):34719-34719 Doi: 10.1038/srep34719 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Orthmann, A; Hoffmann, A; Ernst, C; Golob-Schwarzl, N; Krassnig, S; Haybaeck, J; Jodicke, A; Kuhn, S; Linnebacher, M; Fichtner, I; Hoffmann, J Therapeutic response to chemotherapeutic drugs of glioma-PDX and correlation to common mutations identified by panel sequencing
ONCOL RES TREAT. 2016; 39: 160-160. [Oral Communication]
Web of Science

 

2015

Abstract (Journal)

** Anders, I; Asslaber, M; Golob-Schwarzl, N; Halbwedl, I; Gogg-Kamerer, M; Al-Effah, M; Hoffmann, J; Rolff, J; Popper, H; Haybaeck, J Particular components of the translation machinery drive lung cancer formation
VIRCHOWS ARCH. 2015; 467: S258-S258. [Poster]
Web of Science

 

** Ernst, C; Krassnig, S; Golob-Schwarzl, N; Asslaber, M; Raicht, A; Lederer, E; Spilka, R; Von Campe, G; Orthmann, A; Hoffmann, J; Weis, S; Benesch, M; Haybaeck, J Eukaryotic initiation factors and their contribution to gliomas might be relevant for the development of new therapies
VIRCHOWS ARCH. . 2015; 467: S40-S40. [Oral Communication]
Web of Science

 

** Golob-Schwarzl, N; Schweiger, C; Koller, C; Gogg-Kamerer, M; Uranitsch, S; Lackner, C; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Hoyle, N; Reinhard, C; Lax, S; Haybaeck, J Eukaryotic translation initiation factors are overexpressed in colorectal carcinoma compared to -normal colorectalmucosa: Impact on the RTK/PI3K/Akt-mTOR pathway and putative therapeutic targets
VIRCHOWS ARCH. 2015; 467: S8-S8. [Oral Communication]
Web of Science

 

** Golob-Schwarzl, N; Schweiger, C; Koller, C; Gogg-Kamerer, M; Uranitsch, S; Lackner, C; Punschart, A; Stiegler, P; Keil, M; Hoffmann, J; Henderson, D; Lehrach, H; Hoyle, N; Reinhard, C; Lax, S; Haybaeck, J Modulation of eukaryotic translation initiation factor expression in colorectal carcinoma by cytostatic and targeted medication as demonstrated in xenograft models
VIRCHOWS ARCH. 2015; 467: S166-S166. [Poster]
Web of Science

 

** Lederer, E; Petzold, J; Rehis, R; Ernst, C; Bettermann, K; Golob-Schwarzl, N; Moriggl, R; Schlederer, M; Lax, S; Hoffmann, J; Haybaek, J The role of the JAK/STAT pathway in gallbladder cancer
VIRCHOWS ARCH. 2015; 467: S3-S3. [Oral Communication]
Web of Science

 

2014

Full paper/article (Journal)

** Morisaki, T; Müller, WG; Golob, N; Mazza, D; McNally, JG Single-molecule analysis of transcription factor binding at transcription sites in live cells.
NAT COMMUN. 2014; 5: 4456-4456. Doi: 10.1038/ncomms5456 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2002

Full paper/article (Journal)

** Wronski, R; Golob, N; Grygar, E; Windisch, M Two-color, fluorescence-based microplate assay for apoptosis detection.
Biotechniques. 2002; 32(3):666-668 [OPEN ACCESS]
Web of Science PubMed

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint